β1-integrins and glomerular injury

Journal of Medical Investigation

Volumn 51, Issue 1-2, 2004, Pages 1-13

  Kagami, Shoji ^a   Kondo, Shuji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

1 integrins; Focal adhesion kinase (FAK); Glomerulosclerosis; Mitogen activated protein kinase (MAPK); Platelet derived growth factor (PDGF); Transforming growth factor (TGF )

Indexed keywords

BETA1 INTEGRIN; LIGAND;

CAPILLARY PERMEABILITY; CELL FUNCTION; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS CAPILLARY; HUMAN; KIDNEY INJURY; MESANGIUM CELL; MICROCIRCULATION; NONHUMAN; PATHOGENESIS; PODOCYTE; PROTEIN EXPRESSION; REVIEW; ANIMAL; BIOLOGICAL MODEL; INJURY; MESANGIUM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULARIZATION;

GLOMERULUS;

ANIMALS; ANTIGENS, CD29; EXTRACELLULAR MATRIX; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS; HUMANS; KIDNEY GLOMERULUS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

EID: 1842863088     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.51.1     Document Type: Review

References (88)

1. Ruoslahti E, Obrink B: Common principles in cell adhesion. Common principles in cell adhesion. Exp Cell Res 227: 1-11, 1996
2. Hohenester E, Engel J: Domain structure and organisation in extracellular matrix proteins. Matrix Biol. 21: 115-128, 2002
3. Giancotti FG, Ruoslahti E: Integrin signaling. Science 285: 1028-1032, 1999
4. Danen EH, Yamada KM: Fibronectin, integrins, and growth control. J Cell Physiol 189: 1-13, 2001
5. Kagami S, Kondo S, Loster K, Reutter W, Urushihara M, Kitamura A, Kobayashi S, Kuroda Y: Collagen type I modulates the platelet-derived growth factor (PDGF) regulation of the growth and expression of β1 integrins by rat mesangial cells. Biochem Biophys Res Commun 252: 728-732, 1998
6. Prols F, Hartner A, Schocklmann HO, Sterzel RB: Mesangial cells and their adhesive properties. Exp Nephrol 7: 137-146, 1999
7. Border WA, Noble NA: Transforming growth factor-β in tissue fibrosis. N Engl J Med 331: 1286-1292, 1994
8. Johnson RJ: The glomerular response to injury: Progression or resolution?. Kidney Int 45: 1769-1782, 1994
9. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93: 2431-2437, 1994
10. Burgess ML, Carver WE, Terracio L, Wilson SP, Wilson MA, Borg TK: Integrin-mediated collagen gel contraction by cardiac fibroblasts. Effects of angiotensin II. Circ Res 74: 291-298, 1994
11. Kagami S, Kondo S, Loster K, Reutter W, Kuhara T, Yasutomo K, Kuroda Y: α1β1 integrin-mediated collagen matrix remodeling by rat mesangial cells is differentially regulated by transforming growth factor-β and platelet-derived growth factor-BB. J Am Soc Nephrol 10: 779-789, 1999
12. Danen EH, Sonnenberg A: Integrins in regulation of tissue development and function. J Pathol 200: 471-480, 2003
13. Borges E, Jan Y, Ruoslahti E: Platelet-derived growth factor receptor β and vascular endothelial growth factor receptor 2 bind to the β3 integrin through its extracellular domain. J Biol Chem 275: 39867-39873, 2000
14. Schwartz MA, Baron V: Interactions between mitogenic stimuli, or, a thousand and one connections. Curr Opin Cell Biol 11: 197-202, 1999
15. Adler S, Brady HR: Cell adhesion molecules and the glomerulopathies. Am J Med 107: 371-386, 1999
16. Kagami S, Border WA, Ruoslahti E, Noble NA: Coordinated expression of β1 integrins and transforming growth factor-β-induced matrix proteins in glomerulonephritis. Lab Invest 69: 68-76, 1993
17. Hartner A, Schocklmann H, Prols F, Muller U, Sterzel RB: α8 integrin in glomerular mesangial cells and in experimental glomerulonephritis. Kidney Int 56: 1468-1480, 1999
18. Uchio-Yamada K, Manabe N, Yamaguchi M, Akashi N, Goto Y, Yamamoto Y, Ogura A, Miyamoto H: Localization of extracellular matrix receptors in ICGN mice, a strain of mice with hereditary nephrotic syndrome. J Vet Med Sci 63: 1171-1178, 2001
19. Kuhara T, Kagami S, Kuroda Y: Expression of β1-integrins on activated mesangial cells in human glomerulonephritis. J Am Soc Nephrol 8: 1679-1687, 1997
20. Waldherr R, Cuzic S, Noronha IL: Pathology of the human mesangium in situ. Clin Invest 70: 865-874, 1992
21. Kanahara K, Yorioka N, Arita M, Ohira N, Yamakido M: Immunohistochemical studies of extracellular matrix components and integrins in IgA nephropathy. Nephron 66: 29-37, 1994
22. Jin DK, Fish AJ, Wayner EA, Mauer M, Setty S, Tsilibary E, Kim Y: Distribution of integrin subunits in human diabetic kidneys. J Am Soc Nephrol 7: 2636-2645, 1996
23. Wagrowska-Danilewicz M, Danilewicz M: Pattern of renal β1(α1-α6) integrins distribution in IgA nephropathy and Henoch-Schoenlein nephritis. Pol J Pathol 53: 51-57, 2002
24. Kagami S, Urushihara M, Kondo S, Hayashi T, Yamano H, Loster K, Vossmeyer D, Reutter W, Kuroda Y: Effects of anti-α1 integrin subunit antibody on anti-Thy-1 glomerulonephritis. Lab Invest 82: 1219-1227, 2002
25. Cook HT, Khan SB, Allen A, Bhangal G, Smith J, Lobb RP, Pusey CD: Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis. Am J Pathol 161: 1265-1272, 2002
26. Cosgrove D, Rodgers K, Meehan D, Miller C, Bovard K, Gilroy A, Gardner H, Kotelianski V, Gotwals P, Amatucci A, Kalluri R: Integrin α1β1 and transforming growth factor-β1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy. Am J Pathol 157: 1649-1659, 2000
27. Hartner A, Cordasic N, Klanke B, Muller U, Sterzel RB, Hilgers KF: The α8 integrin chain affords mechanical stability to the glomerular capillary tuft in hypertensive glomerular disease. Am J Pathol 160: 861-867, 2002
28. Kanwar YS: Biophysiology of glomerular filtration and proteinuria. Lab Invest 51: 7-21, 1984
29. Weening JJ, Van Guldener C, Daha MR: The pathophysiology of protein-overload proteinuria. Am J Pathol 129: 64-73, 1987
30. Ryan GB, Karnovsky MJ: An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis. Kidney Int 8: 219-232, 1975
31. Whiteside CI, Cameron R, Munk S and Levy J: Podocytic cytoskeletal disaggregation and basement membrane detachment in puromycin aminonucleoside nephrosis. Am J Pathol 142: 1641-1653, 1993
32. Couser WG: Mediation of immune glomerular injury. J Am Soc Nephrol 1: 13-29, 1990
33. Salant DJ, Madaio MP, Adler S: Altered glomerular permeability induced in rats by F(ab)2 and Fab' antibodies to renal tubular epithelial antigen. Kidney Int 21: 36-43, 1981
34. O'Meara YM, Natori Y, Minto AWM: Nephrotoxic antiserum identifies a β1 integrin on rat glomerular epithelial cells. Am J Physiol 262: F1083-F1091, 1992
35. Adler S, Chen X: Anti-Fx 1 A antibody recognizes a β1-integrin on glomerular epithelial cells and inhibits adhesion and growth. Am J Physiol 262: F770-F776, 1992
36. Adler S, Sharma R, Savin VJ: Alteration of glomerular permeability to macromolecules induced by cross-linking of β1 integrin receptors. Am J Pathol 149: 987-996, 1996
37. Baraldi A, Furci L, Zambruno G: Very late activation-β3 integrin is the dominant β1 integrin on the glomerular capillary wall: an immunofluorescence study in nephrotic syndrome. Nephron 62: 382-388, 1992
38. Shikata K, Makino H, Morioka S: Distribution of extracellular matrix receptors in various forms of glomerulonephritis. Am J Kidney Dis 25: 680-688, 1995
39. Wierzbicka-Patynowski I, Schwarzbauer JE: Regulatory role for SRC and phosphatidylinositol 3-kinase in initiation of fibronectin matrix assembly. J Biol Chem 277: 19703-19708, 2002
40. Wierzbicka-Patynowski I, Schwarzbauer JE: The ins and outs of fibronectin matrix assembly. J Cell Sci 116(Pt 16): 3269-3276, 2003
41. Akiyama SK, Yamada SS, Chen WT, Yamada KM : Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol 109: 863-875, 1989
42. Li S, Van Den Diepstraten C, D'Souza SJ, Chan BM, Pickering JG: Vascular smooth muscle cells orchestrate the assembly of type I Collagen via α2β1 Integrin, RhoA, and Fibronectin polymerization. Am J Pathol 163: 1045-1056, 2003
43. Velling T, Risteli J, Wennerberg K, Mosher DF, Johansson S: Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins α11β1 and α2β1. J Biol Chem 277: 37377-37381, 2002
44. Mendrick DL, Kelly DM, duMont SS, Sandstrom DJ: Glomerular epithelial and mesangial cells differentially modulate the binding specificities of VLA-1 and VLA-2. Lab Invest 72: 367-375, 1995
45. Kagami S, Kuhara T, Yasutomo K, Okada K, Loster K, Reutter W, Kuroda Y: Transforming growth factor-β (TGF-β) stimulates the expression of β1 integrins and adhesion by rat mesangial cells. Exp Cell Res 229: 1-6, 1996
46. Bieritz B, Spessotto P, Colombatti A, Jahn A, Prols F, Hartner A: Role of α8 integrin in mesangial cell adhesion, migration, and proliferation. Kidney Int 64: 119-127, 2003
47. Petermann A, Fees H, Grenz H, Goodman SL: Sterzel RB. Polymerase chain reaction and focal contact formation indicate integrin expression in mesangial cells. Kidney Int 44: 997-1005, 1993
48. Dans MJ, Isseroff R: Inhibition of coragen lattice contraction by pentoxifylline and interferon-α,-β, and-γ. J Invest Dermatol 102: 118-121, 1994
49. Racine-Samson L, Rockey DC, Bissell DM: The role of α1β1 integrin in wound contraction. A quantitative analysis of liver myofibroblasts in vivo and in primary culture. J Biol Chem 272: 30911-30917, 1997
50. Kagami S, Kondo S, Urushihara M, Loster K, Reutter W, Saijo T, Kitamura A, Kobayashi S, Kuroda Y: Overexpression of α1β1 integrin directly affects rat mesangial cell behavior. Kidney Int 58: 1088-1097, 2000
51. Ferri N, Garton KJ, Raines EW: An NF-kappaB-dependent transcriptional program is required for collagen remodeling by human smooth muscle cells. J Biol Chem 278: 19757-19764, 2003
52. Allen-Hoffmann BL, Crankshaw CL, Mosher DF: Transforming growth factor-β increases cell surface binding and assembly of exogenous (plasma) fibronectin by normal human fibroblasts. Mol Cell Biol 8: 4234-4242, 1988
53. Roberts CJ, Birkenmeier TM, McQuillan JJ, Akiyama SK, Yamada SS, Chen WT, Yamada KM, McDonald JA: Transforming growth factor β stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts. J Biol Chem 263: 4586-4592, 1988
54. Pickering JG, Chow LH, Li S, Rogers KA, Rocnik EF, Zhong R, Chan BM: α5β1 integrin expression and luminal edge fibronectin matrix assembly by smooth muscle cells after arterial injury. Am J Pathol 156: 453-465, 2000
55. Weston BS, Wahab NA, Mason RM: CTGF mediates TGF-β-induced fibronectin matrix deposition by upregulating active α5β1 integrin in human mesangial cells. J Am Soc Nephrol 14: 601-610
56. Crean JK, Finlay D, Murphy M, Moss C, Godson C, Martin F, Brady HR: The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells. J Biol Chem 277: 44187-44194, 2002
57. Chatziantoniou C, Dussaule JC: Endothelin and renal vascular fibrosis: of mice and men. Curr Opin Nephrol Hypertens 9: 31-36, 2000
58. Kitamura A, Kagami S, Urushihara M, Kondo S, Yoshizumi M, Tamaki T, Kuroda Y: Endothelin-1 is a potent stimulator of α1β1 integrin-mediated collagen matrix remodeling by rat mesangial cells. Biochem Biophys Res Commun 299: 555-561, 2002
59. Haas CS, Schocklmann HO, Lang S, Kralewski M, Sterzel RB: Regulatory mechanism in glomerular mesangial cell proliferation. J Nephrol 12: 405-415, 1999
60. Sherr CJ: Mammalian G1 cyclins and cell cycle progression. Proc Assoc Am Physicians 107: 181-186, 2003
61. Funk JO, Galloway DA: Inhibiting CDK inhibitors: new lessons from DNA tumor viruses. Trends Biochem Sci 23: 337-341, 1998
62. Zhu X, Ohtsubo M, Bohmer RM, Roberts JM, Assoian RK: Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J Cell Biol 133: 391-403, 1996
63. Renshaw MW, Price LS, Schwartz MA: Focal adhesion kinase mediates the integrin signaling requirement for growth factor activation of MAP kinase. J Cell Biol 147: 611-618, 1999
64. Roovers K, Davey G, Zhu X, Bottazzi ME, Assoian RK: α5β1 integrin controls cyclin D1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells. Mol Biol Cell 10: 3197-3204, 1999
65. Schlaepfer DD, Jones KC, Hunter T: Multiple Grb 2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src-and focal adhesion kinase-initiated tyrosine phosphorylation events. Mol Cell Biol 18: 2571-2585, 1998
66. Wary KK, Mariotti A, Zurzolo C, Giancotti FG: A requirement for caveolin-land associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94: 625-634, 1998
67. Danen EH, Sonneveld P, Sonnenberg A, Yamada KM: Dual stimulation of Ras/mitogen-activated protein kinase and RhoA by cell adhesion to fibronectin supports growth factor-stimulated cell cycle progression. J Cell Biol 151: 1413-1422, 2000
68. Mettouchi A, Klein S, Guo W, Lopez-Lago M, Lemichez E, Westwick JK, Giancotti FG: Integrin-specific activation of Rac controls progression through the G(1)phase of the cell cycle. Mol Cell 8: 115-127, 2001
69. Schocklmann HO, Lang S, Kralewski M, Hartner A, Ludke A, Sterzel RB: Distinct structural forms of type I collagen modulate cell cycle regulatory proteins in mesangial cells. Kidney Int 58: 1108-1120, 2000
70. Kagami S, Urushihara M, Kondo S, Loster K, Reutter W, Tamaki T, Yoshizumi M, Kuroda Y: Requirement for tyrosine kinase-ERK 1/2 signaling in α1β1 integrin-mediated collagen matrix remodeling by rat mesangial cells. Exp Cell Res 268: 274-283, 2001
71. Kagami S, Urushihara M, Kitamura K, Hisayama T, Kitamura M, Löster K, Reutter W, Kuroda Y: PDGF-BB enhances α1β1 integrin-mediated activation of ERK/AP-1 pathway involved in collagen matrix remodeling by rat mesangial cells. J Cell Physiol, 2003 (in press)
72. Zent R, Ailenberg M, Downey GP, Silverman M: ROS stimulate reorganization of mesangial cell-collagen gels by tyrosine kinase signaling. Am J Physiol 276(2 Pt 2): F278-287, 1999
73. Hauck CR, Hsia DA, Schlaepfer DD: Focal adhesion kinase facilitates platelet-derived growth factor-BB-stimulated ERK2 activation required for chemotaxis migration of vascular smooth muscle cells. J Biol Chem 275: 41092-41099, 2000
74. Schwartz MA: Integrin signaling revisited. Trends Cell Biol 11: 466-470, 2001
75. Shen TL, Guan JL: Differential regulation of cell migration and cell cycle progression by FAK complexes with Src, PI 3 K, Grb 7 and Grb 2 in focal contacts. FEBS Lett 499: 176-181, 2001
76. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, Yamamoto T: Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377: 539-544, 1995
77. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, Bell JC, Dedhar S: Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase. Nature 379: 91-96, 1996
78. Wu C, Dedhar S: Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol. 155: 505-510, 2001
79. Guo L, Wu C: Regulation of fibronectin matrix deposition and cell proliferation by the PINCH-ILK-CH-ILKBP complex. FASEB J 16: 1298-1300, 2002
80. Guo L, Sanders PW, Woods A, Wu C: The distribution and regulation of integrin-linked kinase in normal and diabetic kidneys. Am J Pathol 159: 1735-1742, 2001
81. Kagami S, Kondo S, Kitamura A, Urushihara U, Kawachi H, Shimizu F, Kuroda Y: Up-regulation of integrin-linked kinase (ILK) activity in the rat mesangioproliferative glomerulonephritis (GN). J Am Soc Nephrol 13: 500A, 2002
82. Makino H, Sugiyama H, Kashihara N. Apoptosis and extracellular matrix-cell interactions in kidney disease. Kidney Int 77(Suppl): S 67-75, 2000
83. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota A: Apoptosis in glomerular sclerosis. Kidney Int 49: 103-111, 1996
84. Sugiyama H, Kashihara N, Maeshima Y, Okamoto K, Kanao K, Sekikawa T, Makino H: Regulation of survival and death of mesangial cells by extracellular matrix. Kidney Int 54: 1188-1196, 1998
85. Mooney A, Jackson K, Bacon R, Streuli C, Edwards G, Bassuk J: Savill J: Type IV collagen and laminin regulate glomerular mesangial cell susceptibility to apoptosis via β1 integrin-mediated survival signals. Am J Pathol 155: 599-606, 1999
86. Zhang Z, Vuori K, Reed JC, Ruoslahti E: The α5β1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci U S A 92: 6161-6165, 1995
87. Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warne PH, Downward J: Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 16: 2783-2793, 1997
88. King WG, Mattaliano MD, Chan TO, Tsichlis PN, Brugge JS: Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol Cell Biol 17: 4406-4418, 1997